Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06042244 · ClinicalTrials.gov registry record · NA
Multimodal Exercise Training to Reduce Frailty in People With Multiple Sclerosis
A NA study of Multiple Sclerosis and Frailty, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT06042244: Completed NA study of Multiple Sclerosis and Frailty, sponsored by University of Kansas Medical Center.
NCT06042244 is a NA study of Multiple Sclerosis and Frailty that has completed, run by University of Kansas Medical Center. The registered enrollment target is 16 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06042244, a NA study of Multiple Sclerosis and Frailty, has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
Study Significance: This proposed investigation is designed to examine the feasibility of an exercise-based intervention to reduce frailty in people living with MS. The proposed research will be the first to establish the feasibility of targeting frailty in pwMS and will begin to examine the dynamic nature of frailty in MS. These advances will pave the way for planned prospective studies toward effective targets for diagnostics, and rehabilitation of frailty in MS.
Primary Outcome
Preliminary efficacy of multimodal exercise in improving frailty \[Time frame: The EFIP outcome will be assessed at baseline and at 6-weeks post-intervention\] Frailty will be evaluated through the Evaluative Frailty Index for Physical Activity (EFIP).
Conditions Studied
Interventions
- OTHER Waitlist
- OTHER Multimodal Exercise Group
Study Locations (1)
Kansas
- Landon Center On Aging - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2023-11-20 |
| Est. Completion | 2025-02-23 |
| Phase | NA |
What the finished NCT06042244 record still lists
NCT06042244 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Multiple Sclerosis appearing as the primary indexed condition, and to 2 interventions - of which Waitlist is the first listed.
NCT06042244 reports a single indexed study location in Kansas.
Frequently Asked Questions
What is clinical trial NCT06042244 about?
NCT06042244 is a clinical study titled "Multimodal Exercise Training to Reduce Frailty in People With Multiple Sclerosis". Study Significance: This proposed investigation is designed to examine the feasibility of an exercise-based intervention to reduce frailty in people living with MS. The proposed research will be the first to establish the feasibility of targeting frailty in pwMS and will begin to examine the dynamic...
What is the current status of trial NCT06042244?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2023-11-20. Estimated completion is 2025-02-23.
What conditions does trial NCT06042244 study?
This clinical trial studies the following conditions: Multiple Sclerosis, Frailty.
What interventions are being tested in trial NCT06042244?
The interventions under investigation include: Waitlist (OTHER), Multimodal Exercise Group (OTHER).
Who is sponsoring clinical trial NCT06042244?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06042244 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06042244's enrollment target sits among peer trials
16 282nd of 315 higher than 33 of 315 other Multiple Sclerosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Multiple Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Prepare the Mind: Can Coaching in Goal-directed Behaviour Increase the Success of Cognitive Rehabilitation in People With MS?
RECRUITING · NA
-
Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis
RECRUITING · NA
-
Intermittent Hypoxia in Persons With Multiple Sclerosis
RECRUITING · NA
-
Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS
RECRUITING · NA
-
Central Vein Sign in Multiple Sclerosis Extension Study
RECRUITING · NA
-
Effects of Torso Weighting on Muscle Activation During Balance Tests in Individuals With and Without Multiple Sclerosis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI